PERIMETER SOLUTIONS SA (PRM)

LU2391723694 - Common Stock

7.09  0 (0%)

After market: 7.09 0 (0%)

Fundamental Rating

4

Overall PRM gets a fundamental rating of 4 out of 10. We evaluated PRM against 84 industry peers in the Chemicals industry. There are concerns on the financial health of PRM while its profitability can be described as average. PRM is valied quite expensively at the moment, while it does show a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year PRM was profitable.
PRM had a positive operating cash flow in the past year.
In multiple years PRM reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PRM reported negative operating cash flow in multiple years.

1.2 Ratios

PRM has a Return On Assets (2.91%) which is in line with its industry peers.
PRM has a Return On Equity of 5.85%. This is comparable to the rest of the industry: PRM outperforms 54.76% of its industry peers.
PRM has a Return On Invested Capital (4.72%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.91%
ROE 5.85%
ROIC 4.72%
ROA(3y)-6.3%
ROA(5y)-4.09%
ROE(3y)-15.66%
ROE(5y)-10.94%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 20.94%, PRM belongs to the top of the industry, outperforming 94.05% of the companies in the same industry.
In the last couple of years the Profit Margin of PRM has grown nicely.
The Operating Margin of PRM (41.96%) is better than 98.81% of its industry peers.
PRM's Operating Margin has improved in the last couple of years.
The Gross Margin of PRM (43.09%) is better than 88.10% of its industry peers.
In the last couple of years the Gross Margin of PRM has declined.
Industry RankSector Rank
OM 41.96%
PM (TTM) 20.94%
GM 43.09%
OM growth 3Y25.85%
OM growth 5YN/A
PM growth 3Y43.26%
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

PRM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PRM has been reduced compared to 1 year ago.
Compared to 1 year ago, PRM has a worse debt to assets ratio.

2.2 Solvency

PRM has an Altman-Z score of 0.62. This is a bad value and indicates that PRM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, PRM is doing worse than 82.14% of the companies in the same industry.
PRM has a Debt/Equity ratio of 0.68. This is a neutral value indicating PRM is somewhat dependend on debt financing.
PRM has a Debt to Equity ratio (0.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACC0.79
WACC6%

2.3 Liquidity

A Current Ratio of 4.56 indicates that PRM has no problem at all paying its short term obligations.
PRM has a better Current ratio (4.56) than 91.67% of its industry peers.
PRM has a Quick Ratio of 1.91. This is a normal value and indicates that PRM is financially healthy and should not expect problems in meeting its short term obligations.
PRM has a better Quick ratio (1.91) than 79.76% of its industry peers.
Industry RankSector Rank
Current Ratio 4.56
Quick Ratio 1.91

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.82% over the past year.
PRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 39.30% yearly.
Looking at the last year, PRM shows a very negative growth in Revenue. The Revenue has decreased by -10.66% in the last year.
The Revenue has been decreasing by -1.75% on average over the past years.
EPS 1Y (TTM)81.82%
EPS 3Y39.3%
EPS 5YN/A
EPS growth Q2Q76.32%
Revenue 1Y (TTM)-10.66%
Revenue growth 3Y-1.75%
Revenue growth 5YN/A
Revenue growth Q2Q43.96%

3.2 Future

The Earnings Per Share is expected to decrease by -11.99% on average over the next years. This is quite bad
The Revenue is expected to grow by 19.34% on average over the next years. This is quite good.
EPS Next Y-52.87%
EPS Next 2Y-20.02%
EPS Next 3Y-11.99%
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y26.74%
Revenue Next 3Y19.34%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.82, the valuation of PRM can be described as very reasonable.
PRM's Price/Earnings ratio is rather cheap when compared to the industry. PRM is cheaper than 84.52% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. PRM is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 25.07, PRM can be considered very expensive at the moment.
PRM's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.88. PRM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 11.82
Fwd PE 25.07

4.2 Price Multiples

PRM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PRM is cheaper than 73.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.78

4.3 Compensation for Growth

PRM's earnings are expected to decrease with -11.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.02%
EPS Next 3Y-11.99%

0

5. Dividend

5.1 Amount

No dividends for PRM!.
Industry RankSector Rank
Dividend Yield N/A

PERIMETER SOLUTIONS SA

NYSE:PRM (5/3/2024, 7:13:23 PM)

After market: 7.09 0 (0%)

7.09

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.03B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.82
Fwd PE 25.07
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.91%
ROE 5.85%
ROCE
ROIC
ROICexc
ROICexgc
OM 41.96%
PM (TTM) 20.94%
GM 43.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.56
Quick Ratio 1.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)81.82%
EPS 3Y39.3%
EPS 5Y
EPS growth Q2Q
EPS Next Y-52.87%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.66%
Revenue growth 3Y-1.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y